Effect of intravenous ascorbic acid in hemodialysis patients with anemia and hyperferritinemia.

Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia

Volumn 19, Issue 6, 2008, Pages 933-936

  Shahrbanoo, Keyhanian ^a   Taziki, Omolbanin ^a  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; FERRITIN; RECOMBINANT ERYTHROPOIETIN;

ARTICLE; BLOOD; CHEMISTRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REFRACTORY ANEMIA; RENAL REPLACEMENT THERAPY; RETICULOCYTE;

ANEMIA, REFRACTORY; ANTIOXIDANTS; ASCORBIC ACID; ERYTHROPOIETIN, RECOMBINANT; FEMALE; FERRITINS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS; RETICULOCYTES;

EID: 59649103926     PISSN: 13192442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)